Evidence map›Paper›PMID 40366408›Full record

ArticlePediatric nephrology (Berlin, Germany)2025

Genome sequencing identifies RMND1 as a strong candidate gene for severe prenatal kidney failure mimicking renal tubular dysgenesis associated with hyporeninism.

Luisa Marsili, Matthieu Mantecon, Christelle Arrondel, Giulia Barcia, Zahra Assouline, Olivier Gribouval, Diana Wellesley, Victoria Harrison, Pierre Marijon, Cindy Colson and 5 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Luisa MarsiliUniversité de Lille, ULR7364 RADEME, Hôpital Universitaire de Lille, Service de Génétique Clinique, Lille, France.
Matthieu ManteconInstitut Imagine, Genetics of Mitochondrial Diseases, Université Paris Cité, Inserm UMR 1163, Paris, France.
Christelle ArrondelInstitut Imagine, Laboratory of Inherited Kidney Diseases, Université Paris Cité, Inserm UMR U1163, Paris, France.
Giulia BarciaInstitut Imagine, Genetics of Mitochondrial Diseases, Université Paris Cité, Inserm UMR 1163, Paris, France.
Zahra AssoulineAPHP-Centre, Service de Médecine Génomique Des Maladies Rares, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Olivier GribouvalInstitut Imagine, Laboratory of Inherited Kidney Diseases, Université Paris Cité, Inserm UMR U1163, Paris, France.
Diana WellesleyWessex Clinical Genetics Service, University Hospital Southampton, Southampton, UK.
Victoria HarrisonWessex Clinical Genetics Service, University Hospital Southampton, Southampton, UK.
Pierre MarijonLaboratoire de Biologie Médicale MultiSites SeqOIA, Paris, France.
Cindy ColsonUniversité de Lille, ULR7364 RADEME, Hôpital Universitaire de Lille, Service de Génétique Clinique, Lille, France.
Morgane StichelboutCentre de Biologie-Pathologie de Lille, Hôpital Universitaire de Lille, Lille, France.
Marie-Claire GublerInstitut Imagine, Laboratory of Inherited Kidney Diseases, Université Paris Cité, Inserm UMR U1163, Paris, France.
Corinne AntignacInstitut Imagine, Laboratory of Inherited Kidney Diseases, Université Paris Cité, Inserm UMR U1163, Paris, France.
Agnes RotigInstitut Imagine, Genetics of Mitochondrial Diseases, Université Paris Cité, Inserm UMR 1163, Paris, France.
Laurence HeidetInstitut Imagine, Laboratory of Inherited Kidney Diseases, Université Paris Cité, Inserm UMR U1163, Paris, France. laurence.heidet@aphp.fr.ORCID 0000-0002-1362-5515

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal tubular dysgenesis (RTD) is a severe kidney disease characterized by poor development of proximal tubules and persistent fetal anuria leading to oligohydramnios. It can be acquired during fetal life or inherited as an autosomal recessive disease associated with bi-allelic pathogenic variants in one of the genes encoding the renin-angiotensin system (RAS) components, AGT, REN, ACE, or AGTR1. Few cases of RTD remain unsolved despite the lack of fetal cause and comprehensive screening of RAS genes.

methodsWe investigated a case of unsolved RTD with low renin expression by whole genome sequencing, and then screened a series of unsolved RTD by sequencing of a targeted gene panel of genes coding mitochondrial proteins. Oxidative phosphorylation complexes were studied by SDS-PAGE and immunoblotting.

resultsWe identified a rare homozygous variant in RMND1, a gene known to be responsible for an autosomal recessive mitochondrial disease, in a case presenting with RTD-like phenotype with low renin expression but without identified RAS disease-causing variant. We demonstrate a severe reduction of combined oxidative phosphorylation complexes I and IV subunits in this case. Next, we identified another RMND1 homozygous variant in another unsolved RTD case belonging to a consanguineous family with recurrent fetal demise.

conclusionsOur study shows that biallelic RMND1 pathogenic variants likely cause severe prenatal kidney disease presenting with RTD-like phenotype, and prompts to screen RMND1 in unelucidated severe fetal nephropathies to provide diagnosis and, ultimately, genetic counselling. In addition, these data confirm a still poorly understood link between RMND1-associated mitochondrial dysfunction and renin expression.

Indexed as

Urogenital AbnormalitiesFemaleHomozygoteHumansKidney Tubules, ProximalMalePregnancyReninRenin-Angiotensin SystemWhole Genome SequencingReninMitochondriaRenal tubular dysgenesisReninRMND1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.